TGFB1 and idiopathic pulmonary fibrosis: We noticed that one of the mechanisms of the anti‐fibrotic drug, Pirfenidone, for treating idiopathic pulmonary fibrosis is its inhibitory effect on TGF‐β signalling pathway.44